1. Home
  2. PMAX vs PMCB Comparison

PMAX vs PMCB Comparison

Compare PMAX & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Powell Max Limited

PMAX

Powell Max Limited

SELL

Current Price

$2.65

Market Cap

4.5M

Sector

N/A

ML Signal

SELL

Logo PharmaCyte  Biotech Inc.

PMCB

PharmaCyte Biotech Inc.

HOLD

Current Price

$1.06

Market Cap

5.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PMAX
PMCB
Founded
2019
1996
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5M
5.3M
IPO Year
2024
N/A

Fundamental Metrics

Financial Performance
Metric
PMAX
PMCB
Price
$2.65
$1.06
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.7M
9.7M
Earning Date
09-23-2025
12-15-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.01
Revenue
$4,799,100.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$182.71
Revenue Growth
N/A
N/A
52 Week Low
$1.56
$0.63
52 Week High
$25.12
$1.90

Technical Indicators

Market Signals
Indicator
PMAX
PMCB
Relative Strength Index (RSI) 59.40 59.86
Support Level $2.54 $0.71
Resistance Level $3.35 $1.51
Average True Range (ATR) 0.33 0.19
MACD 0.10 0.05
Stochastic Oscillator 67.60 49.06

Price Performance

Historical Comparison
PMAX
PMCB

About PMAX Powell Max Limited

Powell Max Ltd is an financial communications services provider. Its financial communications services cover a full range of financial printing, corporate reporting, communications and language support services from inception to completion, including typesetting, proofreading, translation, design, printing, electronic reporting, newspaper placement and distribution. It operates in a single business segment which is the provision of corporate financial communications and financial printing services. All operations are carried in Hong Kong.

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.

Share on Social Networks: